Dec. 4 at 8:14 PM
$MBIO Mustang Bio ref=
$1.28 — NO pstn, but bullish — thanks for reading the filing @SMM82 , not many here do their homework. Great find re Fred Hutch patent renegotiation.
👍 on a +ve side: cash per share ~
$2.3 right now w runway to 2028+ (as of 2025-09-30 cash=
$19M w 7.3m sh outst and de minimis cash burn per Qtr due to de facto shell/zombie company).
👍Lindy chart - zoom out to 1-2 yrs out!
👍 Tho “old news” and Not recruiting, the 3 malignant glioma Ph1/1b trials — MB-101, MB-108 all Investigator-initiated — could well be recycled for more stock promotional PR, since the data can be analyzed.
See July news https://rarecancernews.com/news/fda-names-mb-101-us-orphan-drug-certain-glioma-types/
Clin Trials MB-101 City of Hope https://clinicaltrials.gov/study/NCT02208362 MB-108 Uni Alabama https://clinicaltrials.gov/study/NCT03657576 MB-108 1b Alabama https://clinicaltrials.gov/study/NCT06614855
Cf
$FBIO Fortress Bio the parent co
🤔
